This discovery is of great biological implication in the sense that it unveils a new apoptosis pathway and sheds light to a potential therapeutic drug—A3D8 which ligates to CD44 and initiates caspase 8 in the pathway—to treat leukemia patients who are resistant to traditional chemotherapy agents ATRA and As2O3. This evidence concerns the gene CASP8 and leukemia.